Smith Group Asset Management
MEDP icon

Smith Group Asset Management’s Medpace MEDP Stock Holding History

Smith Group Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41.5M Sell
66,432
-42,738
-39% -$25M 2.71% 14
2026
Q2 		$57.8M Buy
109,170
+5,567
+5% +$2.57M 2.35% 14
2026
Q1 		$49.7M Buy
103,603
+8,821
+9% +$4.52M 2.54% 12
2025
Q4 		$53.2M Buy
94,782
+7,577
+9% +$4.3M 2.82% 11
2025
Q3 		$44.8M Buy
87,205
+4,982
+6% +$2.18M 2.58% 15
2025
Q2 		$25.8M Buy
82,223
+2,529
+3% +$759K 1.69% 28
2025
Q1 		$24.3M Buy
79,694
+5,436
+7% +$1.83M 1.82% 26
2024
Q4 		$24.7M Sell
74,258
-2,780
-4% -$943K 1.82% 24
2024
Q3 		$25.7M Buy
77,038
+1,809
+2% +$687K 2.13% 18
2024
Q2 		$31M Sell
75,229
-31,394
-29% -$12.4M 2.75% 12
2024
Q1 		$43.1M Sell
106,623
-7,289
-6% -$2.56M 2.47% 4
2023
Q4 		$34.9M Buy
+113,912
New +$30.7M 2.03% 7
2022
Q1 		$347K Sell
2,123
-1,681
-44% -$277K 0.02% 132
2021
Q4 		$828K Sell
3,804
-97
-2% -$20.3K 0.04% 105
2021
Q3 		$738K Sell
3,901
-468
-11% -$85.4K 0.04% 106
2021
Q2 		$772K Sell
4,369
-502
-10% -$86.6K 0.04% 95
2021
Q1 		$799K Sell
4,871
-4,080
-46% -$624K 0.04% 89
2020
Q4 		$1.25M Sell
8,951
-1,550
-15% -$195K 0.07% 92
2020
Q3 		$1.17M Sell
10,501
-2,806
-21% -$324K 0.06% 96
2020
Q2 		$1.24M Sell
13,307
-528
-4% -$44.9K 0.07% 95
2020
Q1 		$1.02M Sell
13,835
-3,155
-19% -$274K 0.06% 94
2019
Q4 		$1.43M Sell
16,990
-300
-2% -$23.2K 0.06% 98
2019
Q3 		$1.45M Sell
17,290
-2,971
-15% -$224K 0.05% 101
2019
Q2 		$1.32M Buy
20,261
+31
+0.2% +$1.79K 0.04% 109
2019
Q1 		$1.19M Sell
20,230
-27,970
-58% -$1.67M 0.04% 113
2018
Q4 		$2.55M Buy
48,200
+10,670
+28% +$586K 0.09% 104
2018
Q3 		$2.25M Buy
+37,530
New +$2.05M 0.06% 126

Other funds holding MEDP

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Riverbridge Partners
Riverbridge Partners Minneapolis, Minnesota $3.41B AUM 6.54% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

Smith Group Asset Management's MEDP Position: Q3 2026 in Review

Smith Group Asset Management reduced its Medpace (MEDP) stake by 39% in Q3 2026, selling an estimated $25M and leaving 66,432 shares worth $41.5M. The position accounts for 2.71% of the portfolio, ranked #14.

Smith Group Asset Management first reported a position in MEDP in Q3 2018 and has held it in 27 quarters since. The position peaked at $57.8M in Q2 2026. 391 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Smith Group Asset Management held 66,432 shares of Medpace worth $41.5M as of Q3 2026.
  • Smith Group Asset Management sold 42,738 Medpace shares in Q3 2026, an estimated $25M.
  • Medpace made up 2.71% of Smith Group Asset Management's portfolio in Q3 2026, its #14 holding.
  • Smith Group Asset Management first reported a position in Medpace in Q3 2018 and has held it in 27 quarters since.
  • Smith Group Asset Management's Medpace position peaked at $57.8M in Q2 2026.
  • 391 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Smith Group Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.